|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-6-26
|
|
pubmed:abstractText |
Overexpression of YKL-40 has been detected in the sera from patients with various kinds of malignant tumors, including epithelial ovarian cancer. Moreover, YKL-40 expression is closely related to clinical phenotypes of some malignant tumors. This study was to investigate the expression and clinical significance of YKL-40 protein in epithelial ovarian cancer tissues.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
142-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19550125-Adipokines,
pubmed-meshheading:19550125-Epithelial Cells,
pubmed-meshheading:19550125-Female,
pubmed-meshheading:19550125-Glycoproteins,
pubmed-meshheading:19550125-Humans,
pubmed-meshheading:19550125-Immunohistochemistry,
pubmed-meshheading:19550125-Lectins,
pubmed-meshheading:19550125-Middle Aged,
pubmed-meshheading:19550125-Neoplasm Staging,
pubmed-meshheading:19550125-Ovarian Neoplasms,
pubmed-meshheading:19550125-Prognosis,
pubmed-meshheading:19550125-Survival Analysis,
pubmed-meshheading:19550125-Tissue Array Analysis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Expression and clinical significance of YKL-40 protein in epithelial ovarian cancer tissues.
|
|
pubmed:affiliation |
Department of Gynecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, PR China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
